<DOC>
	<DOCNO>NCT01577758</DOCNO>
	<brief_summary>This Open-Label , Multicenter , Dose Escalation , First-in-Human Study MLN0264 Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C .</brief_summary>
	<brief_title>Phase 1 Study MLN0264 Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Voluntary consent form Diagnosis GI malignancy GCC protein express tumor Male female patient 18 year older measurable disease define Response Evaluation Criteria Solid Tumors ( RECIST ) Female patient post menopausal , surgically sterile , agree practice 2 effective method contraception agree abstain heterosexual intercourse Male patient agree practice effective barrier contraception agree abstain heterosexual intercourse Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Adequate bone marrow , hepatic renal function specify protocol Female patient lactate positive serum pregnancy test screen period Any serious medical psychiatric illness could interfere completion treatment Major surgery treatment investigational drug first dose Serious infection within 14 day first dose study drug Known HIV , inflammatory bowel disease , viral hepatitis cerebral/meningeal brain metastases Patients cardiovascular condition specify protocols Patients history another primary malignancy remission least 3 year Please note additional inclusion exclusion criterion . The study center determine meet criterion . Site personnel explain trial detail answer question may qualify study . You decide whether wish participate . If qualify trial , site personnel explain reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Phase 1 ,</keyword>
	<keyword>Advanced gastrointestinal malignancy ,</keyword>
	<keyword>MLN0264 ,</keyword>
	<keyword>Guanylyl Cyclase C ( GCC ) ,</keyword>
	<keyword>Antibody Drug Conjugate ( ADC )</keyword>
</DOC>